Padagis Us Company Profile
✉ Email this page to a colleague
What is the competitive landscape for PADAGIS US
PADAGIS US has ninety-two approved drugs.
There is one US patent protecting PADAGIS US drugs.
There are twenty-two patent family members on PADAGIS US drugs in fourteen countries and one hundred and fifty-one supplementary protection certificates in sixteen countries.
Summary for Padagis Us
| International Patents: | 22 |
| US Patents: | 1 |
| Tradenames: | 68 |
| Ingredients: | 64 |
| NDAs: | 92 |
| PTAB Cases with Padagis Us as petitioner: | See PTAB cases with Padagis Us as petitioner |
Drugs and US Patents for Padagis Us
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Padagis Us | BROMOCRIPTINE MESYLATE | bromocriptine mesylate | TABLET;ORAL | 077646-001 | Oct 1, 2008 | AB | RX | No | Yes | ⤷ Start Trial | ⤷ Start Trial | ||||
| Padagis Us | FLUOCINONIDE | fluocinonide | GEL;TOPICAL | 209030-001 | Jun 19, 2018 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Padagis Us | CYCLOSPORINE | cyclosporine | INJECTABLE;INJECTION | 065151-001 | Oct 7, 2003 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Padagis Us | PILOCARPINE HYDROCHLORIDE | pilocarpine hydrochloride | TABLET;ORAL | 076746-001 | Nov 16, 2004 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Padagis Us | TOBRAMYCIN AND DEXAMETHASONE | dexamethasone; tobramycin | SUSPENSION/DROPS;OPHTHALMIC | 212715-001 | Feb 11, 2022 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Padagis Us | TRIAMCINOLONE ACETONIDE | triamcinolone acetonide | OINTMENT;TOPICAL | 087385-003 | Approved Prior to Jan 1, 1982 | AT | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | ||||
| Padagis Us | BACITRACIN ZINC AND POLYMYXIN B SULFATE | bacitracin zinc; polymyxin b sulfate | OINTMENT;OPHTHALMIC | 065022-001 | Feb 27, 2002 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Padagis Us
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Padagis Us | CLINDESSE | clindamycin phosphate | CREAM;VAGINAL | 050793-001 | Nov 30, 2004 | 5,266,329 | ⤷ Start Trial |
| Padagis Us | BUTOCONAZOLE NITRATE | butoconazole nitrate | CREAM;VAGINAL | 019881-001 | Feb 7, 1997 | 5,266,329 | ⤷ Start Trial |
| Padagis Us | BUTOCONAZOLE NITRATE | butoconazole nitrate | CREAM;VAGINAL | 019881-001 | Feb 7, 1997 | 4,078,071 | ⤷ Start Trial |
| Padagis Us | EVAMIST | estradiol | SPRAY;TRANSDERMAL | 022014-001 | Jul 27, 2007 | 6,923,983 | ⤷ Start Trial |
| Padagis Us | BUTOCONAZOLE NITRATE | butoconazole nitrate | CREAM;VAGINAL | 019881-001 | Feb 7, 1997 | 5,993,856 | ⤷ Start Trial |
| Padagis Us | CLINDESSE | clindamycin phosphate | CREAM;VAGINAL | 050793-001 | Nov 30, 2004 | 5,993,856 | ⤷ Start Trial |
| Padagis Us | EVAMIST | estradiol | SPRAY;TRANSDERMAL | 022014-001 | Jul 27, 2007 | 6,978,945 | ⤷ Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for PADAGIS US drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Vaginal Cream | 2% | ➤ Subscribe | 2015-02-05 |
| ➤ Subscribe | Enteric Coated Capsules | 3 mg | ➤ Subscribe | 2008-02-01 |
International Patents for Padagis Us Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| China | 1852690 | ⤷ Start Trial |
| Peru | 20070974 | ⤷ Start Trial |
| Japan | 2009522361 | ⤷ Start Trial |
| European Patent Office | 1968545 | ⤷ Start Trial |
| World Intellectual Property Organization (WIPO) | 2005027807 | ⤷ Start Trial |
| Malaysia | 144021 | ⤷ Start Trial |
| Brazil | PI0620905 | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Padagis Us Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 2365988 | 122018000012 | Germany | ⤷ Start Trial | PRODUCT NAME: PATIROMER SORBITEX CALCIUM UND SALZE DAVON IN ALLEN VOM GRUNDPATENT GESCHUETZTEN FORMEN; REGISTRATION NO/DATE: EU/1/17/1179 20170719 |
| 0617614 | SPC/GB01/014 | United Kingdom | ⤷ Start Trial | PRODUCT NAME: ALITRETINOIN; REGISTERED: UK EU/1/00/149/001 20001018 |
| 1453521 | 132016000025143 | Italy | ⤷ Start Trial | PRODUCT NAME: LEVONORGESTREL ED ETINILESTRADIOLO(SEASONIQUE); AUTHORISATION NUMBER(S) AND DATE(S): 17/0017/15-S, 20150211;042139016, 20150414 |
| 2435024 | 15/2021 | Austria | ⤷ Start Trial | PRODUCT NAME: FORMOTEROLFUMARAT-DIHYDRAT / GLYCOPYRRONIUMBROMID / BUDESONID; REGISTRATION NO/DATE: EU/1/20/1498 (MITTEILUNG) 20201210 |
| 2435024 | SPC/GB21/029 | United Kingdom | ⤷ Start Trial | PRODUCT NAME: A COMBINATION OF FORMOTEROL, INCLUDING PHARMACEUTICALLY ACCEPTABLE SALTS, ESTERS AND SOLVATES THEREOF, GLYCOPYRROLATE, INCLUDING PHARMACEUTICALLY ACCEPTABLE SALTS, ESTERS AND SOLVATES THEREOF, AND BUDESONIDE INCLUDING PHARMACEUTICALLY ACCEPTABLE SALTS, ES; REGISTERED: UK EU/1/20/1498 (NI) 20201210; UK PLGB 17901/0352-001 20201210 |
| 0058146 | 2001C/045 | Belgium | ⤷ Start Trial | PRODUCT NAME: DICHLORHYDRATE DE LEVOCETIRIZINE; NAT RER. NO/DATE: 194 IS 90 F3 20011022; FIRST REG.: DE 49903.00.00 20010103 |
| 2957286 | 122018000145 | Germany | ⤷ Start Trial | PRODUCT NAME: PATIROMER SORBITEX CALCIUM; REGISTRATION NO/DATE: EU/1/17/1179 20170719 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
